Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2018

Nov 5, 2018

30291_dirs_2018-11-05_b6c2fadf-9323-4e1a-931c-a04a603b10cd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2018-10-31

Reporting Person: SHERWIN STEPHEN A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-10-31 Common Stock G 275 Disposed 5739 Direct
2018-10-31 Common Stock G 200 Disposed 5539 Direct
2018-10-31 Common Stock G 200 Disposed 5339 Direct
2018-10-31 Common Stock G 175 Disposed 5164 Direct